Giant Cell Tumor of Tendon Sheath is a growth that forms in the lining of tendons or joints. It's usually found in the wrist or hand. These growths are often benign, but sometimes they can cause pain or need to be removed.
Every report comes from a Lived member, sent anonymously.
Have you tried Romvimza (Vimseltinib) for Giant Cell Tumor of Tendon Sheath?
A giant cell tumor of tendon sheath is a benign (noncancerous) growth that starts in the thin lining around a tendon, or in the similar lining of a joint or bursa (a small fluid-filled cushion near a joint). It usually shows up as a firm, slow-growing lump on the palm side of a finger or hand, and it is often painless. After ganglion cysts, it is the second most common lump found in the hand. Although it does not spread like a cancer, it can press on nearby tissue, wrap around a tendon or nerve, or wear a small groove into bone, and it has a tendency to come back if any of it is left behind. The name comes from the large cells, each with several nuclei (the cell's control centers), seen under the microscope. Doctors now group this tumor with related growths under the name tenosynovial giant cell tumor (TGCT), which comes in two forms. The localized form is a single nodule and is the usual type in the hand and fingers. The diffuse form, also called pigmented villonodular synovitis, spreads through the lining of a large joint, most often the knee, and is harder to remove and more likely to damage the joint.
The exact cause is not known. For many years these growths were thought to be a reaction to inflammation, but most of them carry a change in the cell's genetic material that switches on a signal called CSF1 (colony-stimulating factor 1). That signal draws in large numbers of immune cells, which make up most of the lump. The change is found in the tumor tissue itself. The tumor most often appears between the ages of about 30 and 50, and women are affected somewhat more often than men. Some people recall an earlier injury to the area, but there is no evidence that anything a person did caused it, and there is no known way to prevent it.
Diagnosis starts with an examination of the lump: where it sits, whether it moves with the tendon, whether it is firm rather than fluid-filled, and whether it limits finger movement. A ganglion cyst, the most common hand lump, is filled with fluid, while this tumor is solid, and that difference is often the first clue. Ultrasound is commonly the first imaging test, because it can show that the lump is solid, how it relates to the tendon, nerves and blood vessels, and whether there are separate smaller nodules nearby. MRI (magnetic resonance imaging) gives a more detailed map and is used for larger lumps, unclear ultrasound results or surgical planning. An X-ray can show whether the tumor has pressed into the bone. The diagnosis is confirmed when a pathologist examines the tissue, usually the whole lump after it is removed; for a large or unusual mass near a joint, a biopsy may be done first to rule out a rare cancer such as a sarcoma.
For the localized form, surgery to remove the whole lump is the standard treatment and usually solves the problem. A hand surgeon removes the tumor along with any small satellite nodules while protecting the tendon, nerves and blood vessels around it, often using magnification. Complete removal matters more than anything else, because tissue left behind is the main reason the tumor comes back. Radiation after surgery has been tried for tumors that are hard to remove completely, but it is generally not recommended for the hand or foot. For the diffuse form in a large joint, or for any tenosynovial giant cell tumor where another operation would likely cause severe harm or loss of function, there are now medicines that block the CSF1 signal driving the tumor. Two are approved by the US Food and Drug Administration (FDA) for adults in this situation: pexidartinib (Turalio), capsules taken twice a day, and vimseltinib (Romvimza), a capsule taken twice a week. In clinical trials both shrank tumors in a substantial share of people compared with placebo, and some people also gained movement and had less pain. The main trade-off is the liver: pexidartinib can cause serious and sometimes fatal liver injury, so it is available only through a restricted program with regular blood tests, while vimseltinib also requires liver monitoring. Both medicines can harm a developing pregnancy, so effective contraception is needed during treatment. These medicines are rarely needed for a small hand tumor that can be removed with surgery.
For most people with a localized tumor, surgery removes the lump and relieves any pain or stiffness it was causing. Recovery depends on how large the tumor was and how closely it was wrapped around a tendon, nerve or joint, so ask the surgeon what movement and healing to expect afterward. The tumor does come back in a minority of people. Across studies of hand tumors, about 1 in 8 regrew, often around three years after surgery rather than right away. Regrowth is more likely when the tumor involved a finger joint, sat on the little finger or was not completely removed, and it is usually treated with another operation. Because of this, a surgeon may suggest checking the area for several years. The diffuse form follows a different course. It returns more often after surgery, can gradually wear down the joint and cause arthritis, and some people need several operations, ongoing medicine or eventually a joint replacement.
Have a clinician look at any new firm lump on a finger, hand, foot or near a joint, especially one that is growing, so it can be told apart from a ganglion cyst and, rarely, from something more serious. After surgery, contact your surgeon if a lump returns at or near the scar, or if finger movement or feeling does not recover as expected. A lump that grows quickly or becomes large and painful should be assessed promptly.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Giant Cell Tumor of Tendon Sheath is like, what's helped you, or ask the community a question.